This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.
This content is restricted to subscribers
Continue Reading...
Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.
Members enjoy free PDF downloads on all articles. Join today
Author Affiliations
Department of Psychiatry, Asan Medical Center, Songpa-gu, Seoul, Republic of Korea
Jongno-gu, Seoul, Republic of Korea
Center for Hospital Medicine, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea
Corresponding Author: Seok-Jin Choi, MD, Department of Neurology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea ([email protected]).
Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Republic of Korea
Jongno-gu, Seoul, Republic of Korea
Department of Neurology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Dongjak-gu, Seoul, Republic of Korea
Jongno-gu, Seoul, Republic of Korea
References (44)
Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162–172. PubMedCrossRef
Ng AS, Rademakers R, Miller BL. Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann N Y Acad Sci. 2015;1338(1):71–93. PubMedCrossRef
Lillo P, Savage S, Mioshi E, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler. 2012;13(1):102–109. PubMedCrossRef
Lou JS, Reeves A, Benice T, et al. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60(1):122–123. PubMedCrossRef
Averill AJ, Kasarskis EJ, Segerstrom SC. Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8(4):243–254. PubMedCrossRef
Kurt A, Nijboer F, Matuz T, et al. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs. 2007;21(4):279–291. PubMedCrossRef
Van Heeringen K, Hawton K, Williams JMG. Pathways to suicide: an integrative approach. In: Hawton K, Van Heeringen K, eds. The International Handbook of Suicide and Attempted Suicide. John Wiley & Sons; 2000:223-234.
Druss RG. The Psychology of Illness: in Sickness and in Health. American Psychiatric Publishing; 1995.
Chochinov HM, Wilson KG, Enns M, et al. Depression, hopelessness, and suicidal ideation in the terminally ill. Psychosomatics. 1998;39(4):366–370. PubMedCrossRef
Ribeiro JD, Huang X, Fox KR, et al. Depression and hopelessness as risk factors for suicide ideation, attempts and death: meta-analysis of longitudinal studies. Br J Psychiatry. 2018;212(5):279–286. PubMedCrossRef
Reeve J, Lloyd-Williams M, Dowrick C. Depression in terminal illness: the need for primary care-specific research. Fam Pract. 2007;24(3):263–268. PubMedCrossRef
Nock MK, Borges G, Bromet EJ, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192(2):98–105. PubMedCrossRef
Silva-Moraes MH, Bispo-Torres AC, Barouh JL, et al. Suicidal behavior in individuals with amyotrophic lateral sclerosis: a systematic review. J Affect Disord. 2020;277:688–696. PubMedCrossRef
Centers for Disease Control and Prevention. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). ICD.WHO.INT website. https://icd.who.int/browse10/2019/en. Accessed February 19, 2021.
Gasse C, Danielsen AA, Pedersen MG, et al. Positive predictive value of a register-based algorithm using the Danish National Registries to identify suicidal events. Pharmacoepidemiol Drug Saf. 2018;27(10):1131–1138. PubMedCrossRef
Park S, Rim SJ, Jo M, et al. Comorbidity of alcohol use and other psychiatric disorders and suicide mortality: data from the South Korean National Health Insurance cohort, 2002 to 2013. Alcohol Clin Exp Res. 2019;43(5):842–849. PubMedCrossRef
Chen P-Y, Liu S-K, Chen C-L, et al. Long-term statin use and dementia risk in Taiwan. J Geriatr Psychiatry Neurol. 2014;27(3):165–171. PubMedCrossRef
Chu CY, Cho YT, Jiang JH, et al. Patients with chronic urticaria have a higher risk of psychiatric disorders: a population-based study. Br J Dermatol. 2020;182(2):335–341. PubMedCrossRef
Cunningham R, Sarfati D, Peterson D, et al. Premature mortality in adults using New Zealand psychiatric services. N Z Med J. 2014;127(1394):31–41. PubMed
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509. CrossRef
Borges G, Nock MK, Haro Abad JM, et al. Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys. J Clin Psychiatry. 2010;71(12):1617–1628. PubMedCrossRef
Lee S-U, Park J-I, Lee S, et al. Changing trends in suicide rates in South Korea from 1993 to 2016: a descriptive study. BMJ Open. 2018;8(9):e023144. PubMedCrossRef
Sun FK, Long A, Huang XY, et al. A grounded theory study of action/interaction strategies used when Taiwanese families provide care for formerly suicidal patients. Public Health Nurs. 2009;26(6):543–552. PubMedCrossRef
Hawton K. Restricting access to methods of suicide: rationale and evaluation of this approach to suicide prevention. Crisis. 2007;28(S1):4–9. CrossRef
Hawton K, Townsend E, Deeks J, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ. 2001;322(7296):1203–1207. PubMedCrossRef
Turvill J, Burroughs A, Moore K. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet. 2000;355(9220):2048–2049. CrossRef
Beautrais AL. Suicides and serious suicide attempts: two populations or one? Psychol Med. 2001;31(5):837–845. PubMedCrossRef
Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch Gen Psychiatry. 2005;62(4):427–432. PubMedCrossRef
Brown GK, Beck AT, Steer RA, et al. Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J Consult Clin Psychol. 2000;68(3):371–377. PubMedCrossRef
Nock MK, Borges G, Bromet EJ, et al. Suicide and suicidal behavior. Epidemiol Rev. 2008;30(1):133–154. PubMedCrossRef
Thomson L, Sheehan KA, Meaney C, et al. Prospective study of psychiatric illness as a predictor of weight loss and health related quality of life one year after bariatric surgery. J Psychosom Res. 2016;86:7–12. PubMedCrossRef
Dawood S, Poole N, Fung R, et al. Neurologists’ detection and recognition of mental disorder in a tertiary in-patient neurological unit. BJPsych Bull. 2018;42(1):19–23. PubMedCrossRef
Juul D, Gutmann L, Adams HP Jr, et al. Training in neurology: feedback from graduates about the psychiatry component of residency training. Neurology. 2021;96(5):233–236. PubMed
Eliasen A, Dalhoff KP, Horwitz H. Neurological diseases and risk of suicide attempt: a case-control study. J Neurol. 2018;265(6):1303–1309. PubMedCrossRef
Fang F, Valdimarsdóttir U, Fürst CJ, et al. Suicide among patients with amyotrophic lateral sclerosis. Brain. 2008;131(Pt 10):2729–2733. PubMedCrossRef
Tsai C-P, Chang B-H, Lee CT-C. Underlying cause and place of death among patients with amyotrophic lateral sclerosis in Taiwan: a population-based study, 2003–2008. J Epidemiol. 2013;23(6):424–428. PubMedCrossRef
Bensimon G, Lacomblez L, Meininger V; ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330(9):585–591. PubMedCrossRef
Writing Group; Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16(7):505–512. PubMedCrossRef
Stavroulakis T, Baird WO, Baxter SK, et al. Factors influencing decision-making in relation to timing of gastrostomy insertion in patients with motor neurone disease. BMJ Support Palliat Care. 2014;4(1):57–63. PubMedCrossRef
Bae JS, Hong YH, Baek W, et al; Korean ALS/MND Research Group. Current status of the diagnosis and management of amyotrophic lateral sclerosis in Korea: a multi-center cross-sectional study. J Clin Neurol. 2012;8(4):293–300. PubMedCrossRef
Fang T, Al Khleifat A, Stahl DR, et al; Uk-Mnd LicalS. Comparison of the King’s and MiToS staging systems for ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3–4):227–232. PubMedCrossRef